Within a single, secure, integrated environment, use the power of our AI-driven platform to screen, characterize and optimize drug and vaccine candidates, significantly lowering costs and time-to-market.
Enable a radically different strategy for vaccine development opening the door to attacking rapidly mutating viruses such as influenza, HCV, HIV, or coronaviruses.
Use our platform to assist in the creation and optimization of different types of vaccines such as virus-like particles (VLPs), DNA, and RNA vaccines.
Use our platform to design antibodies that optimize binding affinity, titer, specific productivity, Immunogenicity, or other phenotypic variables of interest.
Engineer viruses that specifically kill cancer cells or equip cells with multiple functions, granting them the ability to invade human cancer-derived cells.